Seoul National University
Lung cancer risk linked to polymorphisms of ataxia telangiectasia mutated gene
Published in Lab Business Week, May 21st, 2006
"The ATM gene is known to be activated by DNA damage and involved in cell cycle arrest, apoptosis and DNA repair. Therefore, ATM gene polymorphisms may act as important factors predicting individual susceptibility to lung cancer," scientists writing in the journal Human Molecular Genetics reported.
"To evaluate the role of ATM gene polymorphisms in lung cancer development, genotypes of the ATM polymorphisms, -4518A>G, IVS21-77C>T, IVS61-55T>C, and IVS62+60G>A, were determined in 616 lung cancer patients and 616 cancer-free...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2006-05-21)
More Articles from Lab Business Week
- Acadia Pharmaceuticals, Inc.
Acadia announces proposed public stock offering - Aida Pharmaceuticals, Inc.
Aida Pharmaceuticals reports 56.8% increase in revenue - Biomerica, Inc.
Biomerica reports diagnostics sales of almost $1M - Bradmer Pharmaceuticals, Inc.
Bradmer commences trading on Toronto Stock Exchange - China Biopharmaceuticals Holdings, Inc.
China Biopharmaceuticals Holdings records 280% increase in revenue - Dynavax Technologies Corporation
Dynavax to advance cancer, hepatitis B, and hepatitis C therapy with $50 million funding - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
